Atherosclerosis and wine

Main Article Content

Bozidar Kocmur*

Abstract

One of the most important risk factors for the origin and development of atherosclerosis is certainly excessive intake of fat in everyday nutrition. This risk factor, and the way it affects the origin and development of atherosclerosis, is described in the article “Atherosclerosis and lymph/risk factors”. In this article, based on verified and proven facts, it is suggested that the primary causes and initiators of atherosclerotic changes in the arterial system of the circulatory system are chylomicrons, especially large ones, which occur under the influence of several risk factors.

Downloads

Download data is not yet available.

Article Details

Kocmur, B. K. (2024). Atherosclerosis and wine. Journal of Cardiovascular Medicine and Cardiology, 11(1), 018–021. https://doi.org/10.17352/2455-2976.000204
Mini Reviews

Copyright (c) 2024 Kocmur B

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992 Jun 20;339(8808):1523-6. doi: 10.1016/0140-6736(92)91277-f. PMID: 1351198.

Vinson JA, Teufel K, Wu N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis. 2001 May;156(1):67-72. doi: 10.1016/s0021-9150(00)00625-0. PMID: 11368998.

Chiva-Blanch G, Magraner E, Condines X, Valderas-Martínez P, Roth I, Arranz S, Casas R, Navarro M, Hervas A, Sisó A, Martínez-Huélamo M, Vallverdú-Queralt A, Quifer-Rada P, Lamuela-Raventos RM, Estruch R. Effects of alcohol and polyphenols from beer on atherosclerotic biomarkers in high cardiovascular risk men: a randomized feeding trial. Nutr Metab Cardiovasc Dis. 2015 Jan;25(1):36-45. doi: 10.1016/j.numecd.2014.07.008. Epub 2014 Aug 2. PMID: 25183453.

da Luz PL, Coimbra SR. Wine, alcohol and atherosclerosis: clinical evidences and mechanisms. Braz J Med Biol Res. 2004 Sep;37(9):1275-95. doi: 10.1590/s0100-879x2004000900001. Epub 2004 Aug 24. PMID: 15334193.

Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995 May 1;91(9):2488-96. doi: 10.1161/01.cir.91.9.2488. PMID: 7729036.

Kocmur B. Atherosclerosis and Lymph// risk factors. J.Cardiovas Med Cardiol. 2020; 7: 281-287.

Kocmur B. The Mechanism of the Emergence of Atherosclerosis. New Perspectives. SM Atherosclerosis J. 2017; 1: 1004.

Kocmur B. Arherosclerosis.Yet chylomicrons, Large, Globe edit, 2020.

VanderLaan PA, Reardon CA, Getz GS. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):12-22. doi: 10.1161/01.ATV.0000105054.43931.f0. Epub 2003 Nov 6. PMID: 14604830.

McGill HC, Geer JC, Strong JP. Natural history of human atherosclerotic lesions. In: Sandler M, Bourne GH, eds. Atherosclerosis and its origin. New York: Academic Press, 1963:39–65.

Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999 Dec 11;319(7224):1523-8. doi: 10.1136/bmj.319.7224.1523. PMID: 10591709; PMCID: PMC28294.

Ruidavets JB, Ducimetière P, Arveiler D, Amouyel P, Bingham A, Wagner A, Cottel D, Perret B, Ferrières J. Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health. 2002 Jan;56(1):24-8. doi: 10.1136/jech.56.1.24. PMID: 11801616; PMCID: PMC1732002.

Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012 Aug 11;380(9841):572-80. doi: 10.1016/S0140-6736(12)60312-2. Epub 2012 May 17. Erratum in: Lancet. 2012 Aug 11;380(9841):564. PMID: 22607825; PMCID: PMC3419820.

Bandeali S, Farmer J. High-density lipoprotein and atherosclerosis: the role of antioxidant activity. Curr Atheroscler Rep. 2012 Apr;14(2):101-7. doi: 10.1007/s11883-012-0235-2. PMID: 22441969.

Rosales C, Davidson WS, Gillard BK, Gotto AM Jr, Pownall HJ. Speciated High-Density Lipoprotein Biogenesis and Functionality. Curr Atheroscler Rep. 2016 May;18(5):25. doi: 10.1007/s11883-016-0572-7. PMID: 27005803.

Havel RJ, Kane JP, Kashyap ML. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest. 1973 Jan;52(1):32-8. doi: 10.1172/JCI107171. PMID: 4345202; PMCID: PMC302224.

Wang HH, Garruti G, Liu M, Portincasa P, Wang DQ. Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances In reverse Cholesterol Transport. Ann Hepatol. 2017 Nov;16(Suppl. 1: s3-105.):s27-s42. doi: 10.5604/01.3001.0010.5495. PMID: 29080338.

Bhattacharya S, Redgrave TG. The content of apolipoprotein B in chylomicron particles. J Lipid Res. 1981 Jul;22(5):820-8. PMID: 7288288.